This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
milla1cf Fri, 02/02/2024 - 17:02 February 2, 2024 — Biosense Webster, Inc. , Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy Atrial Fibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium.
We know that how much AF a patient experiences matters, but we dont know how different durations or patterns impact the risk of future health events. Combining continuous rhythm monitoring with traditional riskfactors has helped clarify how AF burden and patterns can inform risk, prioritization, and treatment decisions, said Jonathan P.
Circulation, Volume 150, Issue Suppl_1 , Page A4141066-A4141066, November 12, 2024. Background:Clinical studies on atrial fibrillation (AF) recurrence after catheter ablation in patients diagnosed with patent foramen ovale (PFO) and paroxysmal AF (PAF) are scarce.
This study investigated the effect of EAT on the risk of SCI after atrial fibrillation catheter ablation (AFCA). We consecutively enrolled patients who underwent AFCA from October 2019 to February 2024. Conclusion LA-EAT is associated with SCI after AFCA and larger LA-EAT volume is an independent riskfactor for SCI.
Nature Reviews Cardiology, Published online: 25 April 2024; doi:10.1038/s41569-024-01036-8 Treatment for periodontal disease might reduce the recurrence of atrial fibrillation (AF) in patients undergoing ablation, suggesting that periodontitis is a modifiable riskfactor for AF.
Image courtesy: ACC christine.book Thu, 02/29/2024 - 11:22 February 29, 2024 — The American College of Cardiology ( ACC ) will soon be holding its ACC 73rd Annual Scientific Session & Expo , ACC.24 24 from April 6 - 8, 2024 in Atlanta, GA at the Georgia World Congress Center.
Circulation, Volume 150, Issue Suppl_1 , Page A4137989-A4137989, November 12, 2024. A notched P wave is also known to predict atrial fibrillation (AF) after catheter ablation. Background:A bimodal P wave in lead II reflects left atrial remodeling and is described as a notched P wave.
The patient was started on amiodarone, anticoagulation, and metoprolol, and scheduled for atrial flutter ablation. He underwent ablation in the EP Lab. Continue Eliquis 5mg BID, should be continued for 3 months == MY Comment , by K EN G RAUER, MD ( 9/18 /2024 ): == I found the following aspects of today's case of special interest.
During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AF).
An international consensus statement on how to treat atrial fibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany.
Launching the first FDA -approved PFA technology is not just a milestone; the PulseSelect PFA system is setting a new standard in safety for AF ablation with excellent efficacy and efficiency 1. In my clinical experience with the catheter, it was designed for AF ablation procedures.
milla1cf Thu, 03/28/2024 - 07:28 March 28, 2024 — Biosense Webster, Inc., patients, were presented as a late-breaker at the 2024 AF Symposium. 1 Among 20 patients who completed the 12-month follow-up visit, 100% achieved acute success from ablation procedures and 80% remained free from atrial arrhythmia recurrence at one year.
Circulation, Volume 150, Issue Suppl_1 , Page A4142952-A4142952, November 12, 2024. All study participants never received alcohol septal ablation or surgical myectomy during follow-up. to 3.36]) after adjustment for known riskfactors. 003) and 2022 ESC risk model (log-likelihood ratios, -268.4 vs -266.2;
Part 2: Empirical Studies in Cardiac Surgery; Risk Model Recommendations The Annals of Thoracic Surgery January 2022 David Shahian Social RiskFactors in Society of Thoracic Surgeons Risk Models.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content